A cGMP Compatible, Non-Viral CAR T Cell Manufacturing Process

Flexible, clinically adaptable, non-viral approaches to CAR TCR methodologiesПодробнее

CAR T-cell Therapy explained (Manufacturing process & how it works)Подробнее

Automated CAR T cell manufacturingПодробнее

Manufacturing CAR T Cells to Accelerate Cancer Immunotherapy ResearchПодробнее

Non-viral T cell engineering for clinical manufacturing [WEBINAR]Подробнее

Applying a closed, modular, semi automated system to CAR T cell therapy manufacturingПодробнее

Manufacturing of CAR T-cells: new approachesПодробнее

Dr. Sehgal on the Structure and Manufacturing Process of CAR T CellsПодробнее

Scalable Manufacturing and Nanovesicle Delivery of CRISPR Cas9 Ribonucleoproteins Using a cGMP...Подробнее

ExPERT Interview: Developing a GMP-Compatible, Large-Scale CAR T Cell Manufacturing with...Подробнее

Making New Drugs: Process Development and Manufacturing of Cellular Therapies under cGMPПодробнее

Quality control in manufacturing CAR-T cell therapiesПодробнее

Strategies to improve CAR T-cell manufacturingПодробнее

Non-viral CAR-T engineering: CARCIK-CD19 for B-ALLПодробнее

CMC Considerations for CAR T Cell Product DevelopmentПодробнее

Current and future state of T cell therapy manufacturing - Closing, automating and preparingПодробнее

CAR-T Cell Therapy Manufacturing WorkflowПодробнее

Manufacturing CAR-T Cell Therapies: The Novartis ApproachПодробнее

CAR T Cells Production for Adoptive Immunotherapy | Protocol PreviewПодробнее

Development of a Semi-Automated Closed CAR-T Manufacturing ProcessПодробнее